Limited information exists regarding the impact of interferons (IFNs) on the information carried by extracellular vesicles (EVs). This study aimed at investigating whether IFN-a2b, IFN-b, IFN-g, and IFN-l1/2 modulate the content of EVs released by primary monocyte-derived macrophages (MDM). Small-EVs (sEVs) were purified by size exclusion chromatography from supernatants of MDM treated with IFNs. To characterize the concentration and dimensions of vesicles, nanoparticle tracking analysis was used. SEVs surface markers were examined by flow cytometry. IFN treatments induced a significant down -regulation of the exosomal markers CD9, CD63, and CD81 on sEVs, and a significant modulation of some adhesion molecules, major histocompatibility complexes and pro -coagulant proteins, suggesting IFNs influence biogenesis and shape the immunological asset of sEVs. SEVs released by IFN-stimulated MDM also impact lymphocyte function, showing significant modulation of lymphocyte activation and IL -17 release. Altogether, our results show that sEVs composition and activity are affected by IFN treatment of MDM.
Giannessi, F., Percario, Z., Lombardi, V., Sabatini, A., Sacchi, A., Lisi, V., et al. (2024). Macrophages treated with interferons induce different responses in lymphocytes via extracellular vesicles. ISCIENCE, 27(6) [10.1016/j.isci.2024.109960].
Macrophages treated with interferons induce different responses in lymphocytes via extracellular vesicles
Giannessi, Flavia;Percario, Zulema;Lombardi, Valentina;Sabatini, Andrea;Sacchi, Alessandra;Lisi, Veronica;Affabris, Elisabetta;
2024-01-01
Abstract
Limited information exists regarding the impact of interferons (IFNs) on the information carried by extracellular vesicles (EVs). This study aimed at investigating whether IFN-a2b, IFN-b, IFN-g, and IFN-l1/2 modulate the content of EVs released by primary monocyte-derived macrophages (MDM). Small-EVs (sEVs) were purified by size exclusion chromatography from supernatants of MDM treated with IFNs. To characterize the concentration and dimensions of vesicles, nanoparticle tracking analysis was used. SEVs surface markers were examined by flow cytometry. IFN treatments induced a significant down -regulation of the exosomal markers CD9, CD63, and CD81 on sEVs, and a significant modulation of some adhesion molecules, major histocompatibility complexes and pro -coagulant proteins, suggesting IFNs influence biogenesis and shape the immunological asset of sEVs. SEVs released by IFN-stimulated MDM also impact lymphocyte function, showing significant modulation of lymphocyte activation and IL -17 release. Altogether, our results show that sEVs composition and activity are affected by IFN treatment of MDM.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
